Similarly, after adjusting for potential confounders in a cross-sectional study, serum C3 levels were independently associated with NAFLD and AFLD, and increased C3 levels were associated with disease severity, which was consistent with our findings (15). This evidence concerns the gene C3 and metabolic dysfunction-associated steatotic liver disease.